Tower Research Capital LLC (TRC) - ANNOVIS BIO INC ownership

ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 14 filers reported holding ANNOVIS BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ANNOVIS BIO INC
ValueSharesWeighting
Q3 2023$6,093
-17.9%
642
+23.7%
0.00%
Q2 2023$7,417
+18917.9%
519
-79.7%
0.00%
-100.0%
Q1 2023$39
+85.7%
2,561
+67.9%
0.00%0.0%
Q4 2022$21
-99.9%
1,525
-9.8%
0.00%
Q3 2022$23,000
+91.7%
1,690
+152.6%
0.00%
Q4 2021$12,000
+71.4%
669
+194.7%
0.00%
Q3 2021$7,000
-88.9%
227
-90.0%
0.00%
-100.0%
Q1 2021$63,000
+950.0%
2,259
+190.4%
0.00%
Q4 2020$6,0000.0%778
-37.1%
0.00%
Q3 2020$6,000
+50.0%
1,236
+20.2%
0.00%
Q2 2020$4,0001,0280.00%
Other shareholders
ANNOVIS BIO INC shareholders Q4 2020
NameSharesValueWeighting ↓
AIGH Capital Management LLC 463,797$3,497,0001.42%
Worth Venture Partners, LLC 119,538$901,0000.71%
Lokken Investment Group LLC 32,211$243,0000.22%
Sterling Investment Advisors, Ltd. 50,588$381,0000.13%
Modera Wealth Management, LLC 43,846$331,0000.03%
Cannell & Co. 10,000$75,0000.00%
Sowell Financial Services LLC 1,529$12,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 14,286$108,0000.00%
BROWN ADVISORY INC 14,942$113,0000.00%
View complete list of ANNOVIS BIO INC shareholders